source
- Oura cancels planned IPO citing market uncertainty despite strong demandOura, known for its smart ring, announced it is withdrawing its initial public offering. The company said the decision was driven by ongoing uncertainty in the IPO market, even though it continues…
- Kodiak Sciences reports Phase 3 success for Zenkuda, matching Eylea in wet AMDKodiak Sciences announced that its experimental therapy Zenkuda achieved comparable efficacy to the market‑leading anti‑VEGF drug Eylea in a late‑stage trial for wet age‑related macular degeneratio…